Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
STRATA Skin Sciences
SSKN
STRATA Skin Sciences
Noninvasive Laser Therapies Will Expand Global Dermatology Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
18 Aug 25
Updated
18 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$12.00
85.1% undervalued
intrinsic discount
18 Aug
US$1.79
Loading
1Y
-34.9%
7D
-5.7%
Author's Valuation
US$12.0
85.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$12.0
85.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-34m
42m
2014
2017
2020
2023
2025
2026
2028
Revenue US$41.9m
Earnings US$5.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.53%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.32%
Calculation
US$5.20m
Earnings '28
x
13.07x
PE Ratio '28
=
US$68.02m
Market Cap '28
US$68.02m
Market Cap '28
/
4.17m
No. shares '28
=
US$16.31
Share Price '28
US$16.31
Share Price '28
Discounted to 2025 @ 12.32% p.a.
=
US$11.51
Fair Value '25